TACTILE SYSTEMS TECHNOLOGY I
TCMDNASDAQTrading Snapshot
- Day Range
- β
- 52-Week Range
- $14.84 β $37.77
- Volume (shares)
- β
- Avg Volume (shares)
- β
- Shares Outstanding
- 22.6M
- Next Earnings
- 2026-11-02
Fundamentals Snapshot
- Annual Revenue
- $330M
- Last Q Revenue
- $86M
- P/E Ratio
- 21.9
- P/S Ratio
- 1.6x
- EPS (TTM)
- $1.08
- Dividend Yield
- β
- Dilution (1yr)
- β5.8%
TACTILE SYSTEMS TECHNOLOGY I
TCMDAbout TACTILE SYSTEMS TECHNOLOGY I
Tactile Systems Technology, Inc. is a medical technology firm that develops and supplies specialized devices to treat chronic health conditions across the United States. Its product portfolio features the Flexitouch Plus system, a pneumatic compression device designed for managing lymphedema. The company also offers the Entre system, a portable pneumatic compression solution for at-home treatment of various venous disorders, including lymphedema, chronic venous insufficiency, and venous leg ulcers. Additionally, Tactile Systems provides the AffloVest, a portable high-frequency chest wall oscillation device used to address retained pulmonary secretions associated with conditions such as bronchiectasis, cystic fibrosis, and certain neuromuscular disorders. Established in 1995, the company maintains its headquarters in Minneapolis, Minnesota.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.